Open AccessContribution and Risks of Left Ventricular Endomyocardial Biopsy in Patients With Cardiomyopathies
Author(s) -
Cristina Chimenti,
Andrea Frustaci
Publication year - 2013
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.13.001414
Subject(s) - medicine , tamponade , cardiology , endomyocardial biopsy , complication , myocarditis , biopsy , perforation , cardiac tamponade , radiology , surgery , materials science , punching , metallurgy
Use of left ventricular (LV) endomyocardial biopsy (EMB) to investigate cardiomyopathies is currently discouraged because it is considered riskier than and as contributive as right ventricular (RV) biopsy. The aim of our study is to report our experience with this option and to discuss its advantages and disadvantages.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom